Visible-light-responsive ZnCuO nanoparticles: Benign photodynamic killers of infectious protozoans

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 6891-6903

  Nadhman, Akhtar ^a   Nazir, Samina ^a   Khan, Malik Ihsanullah ^a   Ayub, Attiya ^a,b   Muhammad, Bakhtiar ^b   Khan, Momin ^a   Shams, Dilawar Farhan ^c   Yasinzai, Masoom ^a,d  

^a QUAID I AZAM UNIVERSITY   (Pakistan)

^b HAZARA UNIVERSITY   (Pakistan)

^c ABDUL WALI KHAN UNIVERSITY   (Pakistan)

^d INTERNATIONAL ISLAMIC UNIVERSITY   (Pakistan)

Author keywords

Doping; Leishmania; Nanoparticles; Photodynamic therapy; Zinc oxide

Indexed keywords

ANTIPROTOZOAL AGENT; COPPER OXIDE NANOPARTICLE; NANOMATERIAL; PHOTOSENSITIZING AGENT; ZINC OXIDE NANOPARTICLE; COPPER; CUPRIC OXIDE; METAL NANOPARTICLE; REACTIVE OXYGEN METABOLITE; ZINC;

AMASTIGOTE; ANTIPROTOZOAL ACTIVITY; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LEISHMANIA; LEISHMANIA TROPICA; LEISHMANIASIS; LIGHT; LUMINESCENCE; MEMBRANE PERMEABILITY; NANOTECHNOLOGY; NECROSIS; NONHUMAN; PAKISTAN; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PROTOZOON; SKIN LEISHMANIASIS; SYNTHESIS; TEMPERATURE MEASUREMENT; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS; CHEMISTRY; CRYSTALLIZATION; CYTOLOGY; DOSE RESPONSE; DRUG DESIGN; DRUG EFFECTS; IC50; MACROPHAGE; METABOLISM; PARASITOLOGY; PARTICLE SIZE; PERMEABILITY; PHOTOCHEMISTRY; PROTOZOAN INFECTIONS; TEMPERATURE; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

APOPTOSIS; COPPER; CRYSTALLIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; HEMOLYSIS; HUMANS; INHIBITORY CONCENTRATION 50; LEISHMANIA; LIGHT; LUMINESCENCE; MACROPHAGES; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; NECROSIS; PARTICLE SIZE; PERMEABILITY; PHOTOCHEMISTRY; PHOTOSENSITIZING AGENTS; PROTOZOAN INFECTIONS; REACTIVE OXYGEN SPECIES; TEMPERATURE; X-RAY DIFFRACTION; ZINC;

EID: 84946882441     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S91666     Document Type: Article

References (47)

1. Morones JR, Elechiguerra JL, Camacho A, et al. The bactericidal effect of silver nanoparticles. Nanotechnology. 2005;16(10):23-46.
2. Kim BY, Rutka JT, Chan WC. Nanomedicine. N Engl J Med. 2010;363(25):2434-2443.
3. Gollnick S, Evans S, Baumann H, et al. Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer. 2003;88(11):1772-1779.
4. Akilov OE, Kosaka S, O'Riordan K, et al. The role of photosensitizer molecular charge and structure on the efficacy of photodynamic therapy against Leishmania parasites. Chem Biol. 2006;13(8): 839-847.
5. Agostinis P, Berg K, Cengel KA, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011;61(4):250-281.
6. Brynildsen MP, Winkler JA, Spina CS, MacDonald IC, Collins JJ. Potentiating antibacterial activity by predictably enhancing endogenous microbial ROS production. Nat Biotechnol. 2013;31(2):160-165.
7. Agnez-Lima LF, Melo JT, Silva AE, et al. DNA damage by singlet oxygen and cellular protective mechanisms. Mut Res. 2012;751(1):15-28.
8. Zhang S, Yang D, Jing D, et al. Enhanced photodynamic therapy of mixed phase TiO2(B)/anatase nanofibers for killing of HeLa cells. Nano Res. 2014;7(11):1659-1669.
9. Arooj S, Nazir S, Nadhman A, et al. Novel ZnO: Ag nanocomposites induce significant oxidative stress in human fibroblast malignant melanoma (Ht144) cells. Beilstein J Nanotechnol. 2015;6(1): 570-582.
10. Hariharan C. Photocatalytic degradation of organic contaminants in water by ZnO nanoparticles: revisited. Applied Catalysis A General. 2006;304:55-61.
11. 3 photocatalysts. Chem Phys Lett. 2008;457(1-3):202-205.
12. Yu H, Irie H, Hashimoto K. Conduction band energy level control of titanium dioxide: toward an efficient visible-light-sensitive photocatalyst. J Am Chem Soc. 2010;132(20):6898-6899.
13. Jacobson RL. Leishmania tropica (Kinetoplastida: Trypanosomatidae): a perplexing parasite. Folia Parasitol (Praha). 2003;50(4):241-250.
14. Hanafi HA, El-Din el SM, El-Hossary SS, et al. Experimental acquisition, development, and transmission of Leishmania tropica by Phlebotomus duboscqi. Acta Trop. 2013;125(1):37-42.
15. Nadhman A, Nazir S, Khan MI, et al. PEGylated silver doped zinc oxide nanoparticles as novel photosensitizers for photodynamic therapy against Leishmania. Free Radic Biol Med. 2014;77:230-238.
16. Kanehara M, Koike H, Yoshinaga T, Teranishi T. Indium tin oxide nanoparticles with compositionally tunable surface plasmon resonance frequencies in the near-IR region. J Am Chem Soc. 2009;131(49):17736-17737.
17. Nederberg F, Zhang Y, Tan JP, et al. Biodegradable nanostructures with selective lysis of microbial membranes. Nature Chem. 2011;3(5):409-414.
18. Filippi-Chiela EC, Oliveira MM, Jurkovski B, Callegari-Jacques SM, da Silva VD, Lenz G. Nuclear morphometric analysis (NMA): screening of senescence, apoptosis and nuclear irregularities. PLoS One. 2012;7(8):e42522.
19. Haidaris C, Bonventre PF. A role for oxygen-dependent mechanisms in killing of Leishmania donovani tissue forms by activated macrophages. J Immunol. 1982;129(2):850-855.
20. George S, Pokhrel S, Xia T, et al. Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping. ACS Nano. 2009;4(1):15-29.
21. Prach M, Stone V, Proudfoot L. Zinc oxide nanoparticles and monocytes: impact of size, charge and solubility on activation status. Toxicol Appl Pharmacol. 2012;266:19-26.
22. Souto-Padrón T. The surface charge of trypanosomatids. An Acad Bras Cienc. 2002;74(4):649-675.
23. Jeng HA, Swanson J. Toxicity of metal oxide nanoparticles in mammalian cells. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2006;41(12):2699-2711.
24. Littlefair PJ. The luminous efficacy of daylight: a review. Lighting Research and Technology. 1985;17(4):162-182.
25. MacIsaac D, Kanner G, Anderson G. Basic physics of the incandescent lamp (lightbulb). The Physics Teacher. 1999;37(9):520-525.
26. Song L, Connolly M, Fernández-Cruz ML, et al. Species-specific toxicity of copper nanoparticles among mammalian and piscine cell lines. Nanotoxicology. 2014;8(4):383-393.
27. Okada Y, Okajima H. Scavenging activity of furan derivatives against hydroxyl radical generated by fenton system. Yakugaku Zasshi. 1998;118(6):226-230.
28. Li Y, Zhang W, Niu J, Chen Y. Mechanism of photogenerated reactive oxygen species and correlation with the antibacterial properties of engineered metal-oxide nanoparticles. ACS Nano. 2012;6(6):5164-5173.
29. Jose GP, Santra S, Mandal SK, Sengupta TK. Singlet oxygen mediated DNA degradation by copper nanoparticles: potential towards cytotoxic effect on cancer cells. J Nanobiotechnol. 2011;9:9.
30. Price M, Reiners JJ, Santiago AM, Kessel D. Monitoring singlet oxygen and hydroxyl radical formation with fluorescent probes during photodynamic therapy. Photochem Photobiol. 2009;85(5):1177-1181.
31. Mohan R, Krishnamoorthy K, Kim S-J. Enhanced photocatalytic activity of Cu-doped ZnO nanorods. Solid State Commun. 2012;152(5):375-380.
32. Wang M, Ren F, Cai G, Liu Y, Shen S, Guo L. Activating ZnO nanorod photoanodes in visible light by Cu ion implantation. Nano Res. 2014;7(3):353-364.
33. Xing G, Xing G, Li M, et al. Charge transfer dynamics in Cu-doped ZnO nanowires. Appl Phys Lett. 2011;98(10):102105-102108.
34. Huang MH, Wu Y, Feick H, Tran N, Weber E, Yang P. Catalytic growth of zinc oxide nanowires by vapor transport. Adv Mater. 2001;13(2):113-116.
35. Hatz S, Lambert JD, Ogilby PR. Measuring the lifetime of singlet oxygen in a single cell: addressing the issue of cell viability. Photochem Photobiol Sci. 2007;6(10):1106-1116.
36. Lin H-F, Liao S-C, Hung S-W. The dc thermal plasma synthesis of ZnO nanoparticles for visible-light photocatalyst. Journal of Photochemistry and Photobiology A: Chemistry. 2005;174(1):82-87.
37. Greenwald RB. Poly(ethylene glycol) anticancer drug delivery systems. P R Health Sci J. 2002;21(2):113-121.
38. Xia T, Kovochich M, Liong M, et al. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano. 2008;2(10):2121-2134.
39. Taveira SF, Lopez RFV. Topical administration of anticancer drugs for skin cancer treatment. In: Caterina AMLa Porta, editor. Skin Cancers - Risk Factors, Prevention and Therapy. Croatia: INTECH Open Access Publisher; 2011:247-272.
40. Allahverdiyev AM, Abamor ES, Bagirova M, et al. Anti-leishmanial effect of silver nanoparticles and their enhanced antiparasitic activity under ultraviolet light. Int J Nanomedicine. 2011;6:2705-2714.
41. Larsen EKU, Nielsen T, Wittenborn T, et al. Accumulation of magnetic iron oxide nanoparticles coated with variably sized polyethylene glycol in murine tumors. Nanoscale. 2012;4(7):2352-2361.
42. Mroz P, Yaroslavsky A, Kharkwal GB, Hamblin MR. Cell death pathways in Photodynamic therapy of cancer. Cancers. 2011;3(2):2516-2539.
43. Carpenter AE, Jones TR, Lamprecht MR, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006;7(10):R100.
44. Ribble D, Goldstein NB, Norris DA, Shellman YG. A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol. 2005;5(1):12.
45. Jimenez-Ruiz A, Alzate JF, MacLeod ET, Luder C, Fasel N, Hurd H. Apoptotic markers in protozoan parasites. Parasit Vectors. 2010;3:104.
46. Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature. 2000;407(6805):784-788.
47. Bakalova R, Ohba H, Zhelev Z, Ishikawa M, Baba Y. Quantum dots as photosensitizers? Nat Biotechnol. 2004;22(11):1360-1361.